Standard effect sizes are more meaningful outcomes in Alzheimer's disease drug trials than the widely used metric of percent slowing of decline, an analysis suggested. In recent trials of Alzheimer's ...

Today’s post is the third, and final, one in a series providing guidance to teachers on how to interpret education research. Cara Jackson currently serves as the president of the Association for ...